Pemirolast — CAS 69372-19-6

Pemirolast is a high-purity Active Pharmaceutical Ingredient (API) classified as an Antiallergic agent and Mast Cell Stabilizer. Mediocon Inc manufactures GMP-compliant Pemirolast at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide. Pemirolast inhibits the release of chemical mediators from mast cells, making it highly effective in allergic and inflammatory conditions including allergic conjunctivitis.

• Allergic conjunctivitis treatment and prevention
• Mast cell stabilization in ocular allergy
• Seasonal and perennial allergic rhinitis adjunct therapy
• Asthma prophylaxis via mediator release inhibition

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support